Diffuse Astrocytoma
What's New
Last Posted: Jun 06, 2023
- Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis.
Pietro Familiari, et al. Anticancer research 2023 0 (6) 2659-2670 - Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours.
Chan Sock Hoai, et al. NPJ genomic medicine 2018 0 30 - [Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas].
Liu Q Q, et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 0 (9) 658-663 - Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid.
Martínez-Ricarte Francisco, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 0 (12) 2812-2819 - Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
Iuchi Toshihiko, et al. Brain tumor pathology 2018 0 (2) 71-80 - Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases.
Kwon Mi Jung, et al. Brain pathology (Zurich, Switzerland) 2019 0 (2) 235-245 - Evaluation of the melting temperature of TaqMan probes as a genotyping method for IDH1, IDH2, and H3F3A in pediatric astrocytomas.
Torres-Caballero Aranxa, et al. Boletin medico del Hospital Infantil de Mexico 2020 0 (6) 303-311 - Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
Ishi Yukitomo, et al. Journal of neurosurgery 2020 0 (3) 733-741 - Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma.
Tunthanathip Thara, et al. Global medical genetics 2021 0 (3) 116-122 - The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study.
Mazzucchi Edoardo, et al. Journal of neurology 2021 0 (5) 2627-2633
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 18, 2024
- Content source: